Welcome to
Cardio&Lung Boost APP
Your all-American app delivers new technologies in the US, aiming at preventing respiratory failure and rehabilitating cardiorespiratory fitness in patients with post-COVID-19 pulmonary fibrosis, with the major goal of benefiting the public and private healthcare sectors in the United States.
The American solution to combat long-COVID
The United States has made significant strides in combating COVID-19, equipping Americans with the necessary tools for protection and treatment. However, a considerable number of individuals are still grappling with a prolonged illness known as "Long COVID." These individuals experience persistent, debilitating symptoms that can persist long after the initial COVID-19 infection has resolved, resembling symptoms seen in other chronic medical conditions
Data
Post-COVID-19 consists of a period after recovering from COVID-19 infection. It is characterized by persistent symptoms such as fatigue, shortness of breath, brain fog, and muscle weakness, collectively known as long COVID. These symptoms can last for weeks or months, affecting the quality of life and requiring ongoing medical care and support. Severe cases of long COVID can lead to the development of serious lung diseases, aggravating one's health further.
1 in 5
Adults may have post-COVID-related health conditions
18%
of anuall growth of American telemedicine market
56+
USD Billion in Global Remote Patient Monitoring in 2022
Meet Experienced Leader:
Priscila Oliveira
Founder & CEO
Priscila has extensive experience in the medical field, having worked in multiple companies in Brazil and the United Kingdom. She has worked with adults and in pediatrics, specializing in respiratory therapy, patient planning and monitoring, massage therapy, ergonomics, and many other areas.
Priscila has a Bachelor's degree in Physiotherapist; a Specialization in Global Postural Reeducation to the proprioceptive and Muscular Balance; and over 20 years of progressive professional experience.